Cantabio Pharmaceuticals Inc. Share Price Other OTC
Equities
CTBO
US13808X2036
Biotechnology & Medical Research
Sales 2017 | - | Sales 2018 | - | Capitalization | 2.36M 188M |
---|---|---|---|---|---|
Net income 2017 | -1M -79.63M | Net income 2018 | -2M -159M | EV / Sales 2017 | - |
Net Debt 2017 | 337K 26.84M | Net Debt 2018 | 1.1M 87.22M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-
| Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 29.99% |
Managers | Title | Age | Since |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 05/02/12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 21/05/15 |
Max Zhu
BRD | Director/Board Member | 42 | 31/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 21/05/15 |
Gergely Tóth
FOU | Founder | 51 | 05/02/12 |
Max Zhu
BRD | Director/Board Member | 42 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |